Myriad Genetics, Inc. Announces Upcoming Investor Event

Published: Dec 06, 2013

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SALT LAKE CITY, Dec. 5, 2013 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that it will be hosting an investor event for research analysts and institutional investors on Thursday, December 12, 2013 at 8:30 p.m. EST in San Antonio, Texas. Mark Capone, president of Myriad Genetic Laboratories; Richard Wenstrup M.D., chief medical officer; John Ryan, senior director of operations; and Larry Geier M.D., assistant professor at Kansas University Medical School will be presenting at the event. The focus of the meeting will be on Myriad's new myRisk Hereditary Cancerâ„¢ test. If you are interested in attending please contact Myriad's investor relations team for the event details.

Help employers find you! Check out all the jobs and post your resume.

Back to news